Nutrafol Brushes Too Broadly With Hair Re-Growth Claims – ERSP
This article was originally published in The Rose Sheet
Executive Summary
Nutraceutical Wellness will modify claims for Nutrafol Hair Re-Growth Supplement after ERSP finds two should be narrowed to clarify that ingredients and not the product were tested and that external factors impact hair health.
You may also be interested in...
Unilever Targets Hair Health From Inside-Out With Nutrafol Acquisition
After five years with a minority interest in Nutrafol for “clinically proven hair growth,” Unilever will acquire a majority stake in the supplements brand under undisclosed terms. Nutrafol says its nutraceuticals for men and women – sold through multiple channels including by more than 3,000 physicians – target “the six root causes affecting hair health.”
NAD: Firm's Laser Cap Hair-Regrowth Claims Not Supported, Despite FDA Clearance
The Capillus82 Hair Regrowth Laser Cap may be "substantially equivalent" to the manufacturer's Capillus272 Pro device, based on FDA's 510(k) clearance, but NAD says hair-growth clinical findings from that "predicate" device cannot serve to substantiate claims for the untested Capillus82. The case illustrates complexities in the medical device segment, which increasingly is of interest to cosmetics companies.
Unilever Private Equity Arm Supports Hair Regrowth Supplement Firm
Consumer goods giant Unilever's private equity arm Unilever Ventures is lead investor in hair growth nutraceutical firm Nutrafol. Unilever Ventures has more than $489m under management in investments in dozens of hair care, food and digital technology brands.